Use of the pat nonapeptide in treating and preventing neurodegenerative diseases
FR2977159A1
Composition in form of orodispersible tablet, useful for treating/preventing Alzheimer's disease, comprises memantine/amantadine or their salts as active ingredients, where bitterness of ingredients is masked by sweetener
FR2954320A1
Supplementally available oral pharmaceutical composition containing biphosphonic acid or one of its salts
WO2009150310A1
Use of the pat nonapeptide in the treatment of autoimmune diseases
FR2932387A1
Oral composition containing an antiplatelet agent of the family of thienopyridines in the basic form.
FR2931678A1
Use of trilistane for the treatment of low pressure
FR2919802A1
Process for solubilization of essential oils in water
FR2841138A1
Solid pharmaceutical composition comprising a lipophilic active ingredient, its preparation process
FR2821552A1
Process for making hydrosoluble an active ingredient naturally little or not soluble in water and uses thereof
FR2818905A1
MICELLAR COLLOIDAL PHARMACEUTICAL COMPOSITIONS COMPRISING A LIPOPHILIC ACTIVE INGREDIENT
FR2814679A1
Dispersible pharmaceutical compositions based on cephalosporins, process for their preparation and their use
FR2807662A1
PROCESS FOR STABILIZING THE SIZE OF AN ACTIVE INGREDIENT DISPERSE IN A LIQUID AND ITS APPLICATIONS
FR2798289A1
Quickly deliting mouth galenic forms and their preparation method
FR2793690A1
Pharmaceutical formulations in macrolides alone or associated with other active ingredients and their use in therapeutics
FR2783421A1
Process for the preparation of novel galenic formulations of fenofibrate, galenic formulations obtained by said process and their applications
